omega-n-methylarginine has been researched along with tranylcypromine in 2 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (tranylcypromine) | Trials (tranylcypromine) | Recent Studies (post-2010) (tranylcypromine) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 1,826 | 94 | 183 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | tranylcypromine (IC50) |
---|---|---|---|
Lysine-specific histone demethylase 1A | Homo sapiens (human) | 4.64 | |
Cytochrome P450 1A1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2E1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 3.585 | |
Cytochrome P450 2C8 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2A6 | Homo sapiens (human) | 2.7133 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 3.38 | |
Cytochrome P450 4B1 | Homo sapiens (human) | 6.2 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.078 | |
Cytochrome P450 2B6 | Homo sapiens (human) | 6.4533 | |
Cytochrome P450 3A5 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2A7 | Homo sapiens (human) | 6.2 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.29 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3.6436 | |
Cytochrome P450 3A7 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2F1 | Homo sapiens (human) | 6.2 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.0871 | |
Cytochrome P450 2C18 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 4.87 | |
Cytochrome P450 2J2 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4F2 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4F8 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4A11 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4F3 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2A13 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4A22 | Homo sapiens (human) | 6.2 | |
Vitamin D 25-hydroxylase | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2U1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2W1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2S1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 3A43 | Homo sapiens (human) | 6.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ea Kim, L; Javellaud, J; Oudart, N | 1 |
Nakano, Y; Okatani, Y; Sagara, Y; Watanabe, K | 1 |
2 other study(ies) available for omega-n-methylarginine and tranylcypromine
Article | Year |
---|---|
Endothelium-dependent relaxation of rabbit middle cerebral artery to a histamine H3-agonist is reduced by inhibitors of nitric oxide and prostacyclin synthesis.
Topics: Animals; Arginine; Cerebral Arteries; Dexamethasone; Endothelium, Vascular; Epoprostenol; In Vitro Techniques; Indomethacin; Methylhistamines; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Rabbits; Receptors, Histamine; Receptors, Histamine H3; Tranylcypromine; Vasodilator Agents | 1992 |
Relaxant effect of nitric oxide and prostacyclin on serotonin-induced vasocontraction of human umbilical artery.
Topics: Arginine; Drug Interactions; Enzyme Inhibitors; Epoprostenol; Female; Humans; Methylene Blue; Monoamine Oxidase Inhibitors; Nitric Oxide; omega-N-Methylarginine; Platelet Aggregation Inhibitors; Pregnancy; Receptors, Serotonin; Serotonin; Tranylcypromine; Umbilical Arteries; Vasoconstriction; Vasodilation | 1996 |